"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal" by Umashankar K Ballehaninna

Selected Works of Ronald Chamberlain, MD, MPA, FACS

Article

The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal

Journal of gastrointestinal oncology (2012)

Umashankar K Ballehaninna
Ronald S Chamberlain

Link

Disciplines

Medicine and Health Sciences,
Gastroenterology,
Pathology and
Internal Medicine

Publication Date

June 1, 2012

DOI

10.3978/J.ISSN.2078-6891.2011.021

Citation Information

Umashankar K Ballehaninna and Ronald S Chamberlain. "The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal" Journal of gastrointestinal oncology Vol. 3 Iss. 2 (2012) p. 105 - 119
Available at: http://works.bepress.com/ronald-chamberlain/128/